awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34517849-2BF4F81E-AF90-4B9F-A493-286F3C384E34
Q34517849-2BF4F81E-AF90-4B9F-A493-286F3C384E34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34517849-2BF4F81E-AF90-4B9F-A493-286F3C384E34
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
P2860
Q34517849-2BF4F81E-AF90-4B9F-A493-286F3C384E34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34517849-2BF4F81E-AF90-4B9F-A493-286F3C384E34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57ff6536e198b52274c90538b77964ea0948b396
P2860
KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties.